Ewan Campbell

I have over 30 years experience in Healthcare covering pre-clinical, Regulatory, Clinical Trials, post marketing,manufacturing and Quality. I was involved in the first therapeutic antibodies (anti-D), First Gene Therapy approval in Europe (Glybera), The Endeavor PC coated Drug eluting coronary stent and the first Ebola Vaccine. I have been involved in 3 successful start ups The First floated on the London Main Market (Drug eluting stents), Second on the AIM (advanced therapy) and the Third was acquired in 1999 (Clinical Contract Research Organization). I am also a Qualified Person for Gene and Cell Therpies.